Development of 68Ga-NOTA-cRGD Probe Mediated by Sulfenic Acid for Prolonging Tumor Imaging
- Xinyu Xue 1, Wenfang Liao 1, Xiaotian Guo 1, Fei Chen 1, Bao Zhu 1
- Xinyu Xue 1, Wenfang Liao 1, Xiaotian Guo 1
- 1Department of Nuclear Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu 214023, P. R. China.
- 0Department of Nuclear Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu 214023, P. R. China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces a new diagnostic probe, <sup>68</sup>Ga-NOTA-cRGD, which uses 1,3-cyclohexanedione to improve tumor targeting and imaging. The enhanced probe shows better cell uptake and longer imaging times in tumors.
Area Of Science
- Biomedical Imaging
- Radiochemistry
- Oncology
Background
- Reactive oxygen species (ROS) are key signaling molecules in the tumor microenvironment, influencing tumor growth, drug resistance, and metastasis.
- 1,3-cyclohexanedione-based probes offer potential for real-time monitoring of ROS in tumors.
Purpose Of The Study
- To synthesize and evaluate a novel tumor diagnostic probe, <sup>68</sup>Ga-NOTA-cRGD, incorporating a 1,3-cyclohexanedione moiety.
- To investigate the probe's ability to enhance tumor targeting and prolong imaging time by cross-linking with sulfenic acid.
Main Methods
- Synthesis of <sup>68</sup>Ga-NOTA-cRGD probe featuring a 1,3-cyclohexanedione group linking NOTA and cRGD peptide.
- In vitro and in vivo evaluation of the probe's radiolabeling efficiency, stability, cell uptake, and biodistribution compared to a control probe lacking the 1,3-cyclohexanedione group.
Main Results
- Efficient and stable radiolabeling with excellent physiological stability was achieved.
- The 1,3-cyclohexanedione-containing probe (<sup>68</sup>Ga-NOTA-cRGD-2) showed superior cell uptake, tumor imaging contrast, and biodistribution compared to the control (<sup>68</sup>Ga-NOTA-cRGD-1).
- Enhanced cell affinity and a prolonged in vivo biological half-life were observed, with higher uptake in A549 tumor cells.
Conclusions
- The 1,3-cyclohexanedione moiety significantly enhances tumor-targeting capability and prolongs the retention of the diagnostic probe in tumors.
- This finding provides a foundation for developing more effective tumor diagnostic probes utilizing this chemical group.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

